Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drawing, stories, or toy masks: a trial tests whether fun can tame kids' fear of nebulizer treatment

NCT ID NCT06510166

Symptom relief Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether distraction techniques—like drawing, reading a story, watching a cartoon, or using a toy nebulizer and mask—can lower fear and anxiety in children aged 3 to 6 during inhalation therapy for respiratory infections. Children are randomly assigned to one of three groups: standard nebulizer plus a distraction activity, a toy nebulizer with a toy mask, or standard care alone. The goal is to see if these simple, playful approaches make treatment less stressful.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
distraction techniques (drawing, story, cartoon) and toy nebulizer with toy mask
What this could lead to
If it works, this could point toward simple, low-cost ways to make inhalation therapy less scary for young children.
What could go wrong
This is a small, early-stage trial with 120 children, so results may not apply broadly. The effect of distraction may vary by child temperament.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Apr 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 6 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parent and child volunteer to participate in the study, * The child is between 3-6 years old, * Presentation due to upper and lower respiratory tract infection, * Inhaler treatment will be applied with a nebulizer, * No request for any other intravenous, intramuscular or invasive treatment, * The child does not have any genetic, congenital, chronic or metabolic disease, Exclusion Criteria: * Parent and child are not willing to participate in the study, * The child is not between 3-6 years old, * Presentation for a reason other than upper and lower respiratory tract infection, * No inhaler treatment with a nebulizer, * Request for any other intravenous, intramuscular or invasive treatment, * The child has any genetic, congenital, chronic or metabolic disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder phobic disorder primary interstitial lung disease specific to childhood

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Child Distraction methods FEAR Inhalation therapy; complications

Contacts and locations

Locations

  • Ondokuz Mayıs University

    Samsun, Atakum, 55139, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.